Cargando…
Changes in methadone take-home dosing before and after COVID-19
INTRODUCTION: In response to the COVID-19 pandemic, a federal exemption allowed stable and less stable patients greater take-home doses of methadone. We assessed the adoption of increased take-home medication during COVID-19 and whether increased take-home doses is associated with clients' char...
Autores principales: | Amram, Ofer, Amiri, Solmaz, Thorn, Emily L., Lutz, Robert, Joudrey, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223136/ https://www.ncbi.nlm.nih.gov/pubmed/34304950 http://dx.doi.org/10.1016/j.jsat.2021.108552 |
Ejemplares similares
-
Availability of timely methadone treatment in the United States and Canada during COVID-19: A census tract-level analysis
por: Amram, Ofer, et al.
Publicado: (2023) -
Changes to methadone maintenance therapy in the United States, Canada, and Australia during the COVID-19 pandemic: A narrative review
por: Panwala, Victoria, et al.
Publicado: (2023) -
Racial, Ethnic, and Sex Differences in Methadone-Involved Overdose Deaths Before and After the US Federal Policy Change Expanding Take-home Methadone Doses
por: Harris, Rebecca Arden, et al.
Publicado: (2023) -
Treatment provider perceptions of take-home methadone regulation before and during COVID-19
por: Madden, Erin Fanning, et al.
Publicado: (2021) -
Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemic
por: Dunn, Kelly E., et al.
Publicado: (2021)